KRISTEN MEERBREY to Protein Kinase Inhibitors
This is a "connection" page, showing publications KRISTEN MEERBREY has written about Protein Kinase Inhibitors.
Connection Strength
0.070
-
Modulating Androgen Receptor-Driven Transcription in Prostate Cancer with Selective CDK9 Inhibitors. Cell Chem Biol. 2021 02 18; 28(2):134-147.e14.
Score: 0.060
-
Overcoming endocrine resistance due to reduced PTEN levels in estrogen receptor-positive breast cancer by co-targeting mammalian target of rapamycin, protein kinase B, or mitogen-activated protein kinase kinase. Breast Cancer Res. 2014 Sep 11; 16(5):430.
Score: 0.010